Business & Economy
0 1 min read

Professor Dr. Zabrul SM Haque, CEO of Asgar Ali Hospital, presiding over a scientific seminar on “Management of diabetes during Ramzan and Empagliflozin- A groundbreaking innovation for T2DM” organized by NIPRO JMI Pharma Limited at the hospital as chairperson. Md. Mizanur Rahman, CEO of NIPRO JMI Pharma Limited and Dr. Rushda Sharmin Binte Rouf among others were also spoked in the seminar.

Professor Dr. Zabrul SM Haque, CEO of Asgar Ali Hospital, presiding over a scientific seminar on "Management of diabetes during Ramzan and Empagliflozin- A groundbreaking innovation for T2DM" organized by NIPRO JMI Pharma Limited at the hospital as chai
Professor Dr. Zabrul SM Haque, CEO of Asgar Ali Hospital, presiding over a scientific seminar on "Management of diabetes during Ramzan and Empagliflozin- A groundbreaking innovation for T2DM" organized by NIPRO JMI Pharma Limited at the hospital as chai
block
admin

.

block